Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-naïve”

957 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 957 results

Testing effectiveness (Phase 2)UnknownNCT02825836
What this trial is testing

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Who this might be right for
Relapsed/Refractory B Cell MalignanciesMantle Cell Lymphoma and Diffuse Large B Cell LymphomaChronic Lymphocytic Leukemia+2 more
Telios Pharma, Inc. 130
Post-approval studies (Phase 4)UnknownNCT02404233
What this trial is testing

Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects

Who this might be right for
HIV Positive
Therapeutic Concepts 30
Testing effectiveness (Phase 2)Study completedNCT00947349
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) Patients

Who this might be right for
Hepatitis CPharmacokinetics
Boehringer Ingelheim 22
Large-scale testing (Phase 3)Study completedNCT01691755
What this trial is testing

Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 196
Testing effectiveness (Phase 2)Study completedNCT02493855
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 46
Large-scale testing (Phase 3)Active Not RecruitingNCT05215340
What this trial is testing

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo 740
Large-scale testing (Phase 3)Ended earlyNCT00496158
What this trial is testing

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus

Who this might be right for
Chronic HepatitisHepatitis B
Pharmasset
Large-scale testing (Phase 3)Study completedNCT02288247
What this trial is testing

Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Europe Ltd. 688
Not applicableLooking for participantsNCT07126678
What this trial is testing

Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma

Who this might be right for
Follicular LymphomaTreatment Naive
The First Affiliated Hospital with Nanjing Medical University 15
Testing effectiveness (Phase 2)Study completedNCT02582684
What this trial is testing

Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Not applicableStudy completedNCT00525733
What this trial is testing

Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)

Who this might be right for
HIV Infections
Rockefeller University 40
Large-scale testing (Phase 3)Study completedNCT01567735
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 107
Early research (Phase 1)Ended earlyNCT04548700
What this trial is testing

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

Who this might be right for
Treatment-naïvePeripheral T Cell Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 38
Post-approval studies (Phase 4)Study completedNCT00242216
What this trial is testing

"The Once A Day Protease Inhibitor Regimens"

Who this might be right for
HIV Infections
The University of Texas Health Science Center, Houston 76
Early research (Phase 1)Study completedNCT03516214
What this trial is testing

EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations

Who this might be right for
Bronchial Neoplasms
University of Cologne 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03682536
What this trial is testing

Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Who this might be right for
Myelodysplastic Syndromes
Celgene 363
Early research (Phase 1)Study completedNCT03022409
What this trial is testing

Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).

Who this might be right for
Head and Neck Squamous Cell Carcinoma
AstraZeneca 21
Large-scale testing (Phase 3)Study completedNCT04180488
What this trial is testing

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

Who this might be right for
Chronic Spontaneous Urticaria
Sanofi 397
Post-approval studies (Phase 4)Study completedNCT01988662
What this trial is testing

UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)

Who this might be right for
Neovacular Age-related Macular Degeneration
Novartis Pharmaceuticals 205
Testing effectiveness (Phase 2)Active Not RecruitingNCT06757010
What this trial is testing

NE3107 in Early Parkinson's

Who this might be right for
Parkinsons Disease (PD)
BioVie Inc. 60
Load More Results